Until recent years, best practice treatment of T1D, as was established in the Diabetes Control and Complications Trial [6], involved frequent self-monitoring of blood glucose level through using finger pricks to access capillary blood and multiple daily injections of short- and long-acting insulins. This evidence concerns the gene INS and diabetes mellitus.